Jian Jin Selected Research

Infections

5/2022	m6A Demethylase ALKBH5 Restrains PEDV Infection by Regulating GAS6 Expression in Porcine Alveolar Macrophages.
1/2022	Insight into mechanisms of pig lncRNA FUT3-AS1 regulating E. coli F18-bacterial diarrhea.
2/2021	Porcine epidemic diarrhea virus infections induce autophagy in Vero cells via ROS-dependent endoplasmic reticulum stress through PERK and IRE1 pathways.
1/2020	Development of a PHMB hydrogel-modified wound scaffold dressing with antibacterial activity.
1/2019	Low-dose adefovir dipivoxil-induced hypophosphatemia osteomalacia in five chronic hepatitis B virus-infected patients. Is low-dose adefovir dipivoxil-induced nephrotoxicity completely reversible?
7/2018	Gut Microbial β-Glucuronidase Inhibition via Catalytic Cycle Interception.
1/2018	Influenza virus infection causes global RNAPII termination defects.
11/2017	A new cordycepin-producing caterpillar fungus Ophiocordyceps xuefengensis with artificial infection to the host, cultivation of mycelia and stromata.
5/2017	17α-HYDROXYLASE/17, 20-LYASE DEFICIENCY: CLINICAL AND MOLECULAR CHARACTERIZATION OF EIGHT CHINESE PATIENTS.
5/2016	Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jian Jin Research Topics

Disease

110	Neoplasms (Cancer) 03/2022 - 08/2009
33	Breast Neoplasms (Breast Cancer) 10/2022 - 05/2006
12	Inflammation (Inflammations) 01/2021 - 01/2011
11	Fibrosis (Cirrhosis) 07/2022 - 08/2014
11	Infections 05/2022 - 03/2004
11	Carcinogenesis 01/2022 - 02/2014
8	Neoplasm Metastasis (Metastasis) 02/2022 - 09/2013
7	Diabetes Mellitus 03/2019 - 04/2013
6	Leukemia 01/2022 - 01/2013
6	Non-alcoholic Fatty Liver Disease 11/2021 - 04/2019
6	Multiple Myeloma 01/2021 - 02/2016
5	Triple Negative Breast Neoplasms 07/2022 - 04/2012
5	Hepatocellular Carcinoma (Hepatoma) 11/2021 - 01/2014
5	Fatty Liver 01/2021 - 01/2019
5	Wounds and Injuries (Trauma) 11/2020 - 01/2015
5	Melanoma (Melanoma, Malignant) 01/2020 - 09/2008
5	Ovarian Neoplasms (Ovarian Cancer) 11/2017 - 09/2013
4	Necrosis 07/2022 - 11/2018
4	Mitochondrial Diseases (Mitochondrial Disease) 07/2022 - 01/2017
4	Thyroid Neoplasms (Thyroid Cancer) 03/2022 - 01/2019
4	Hyperglycemia 01/2021 - 01/2016
4	Catalepsy 01/2021 - 11/2011
4	Colonic Neoplasms (Colon Cancer) 08/2018 - 01/2014
4	Colorectal Neoplasms (Colorectal Cancer) 11/2017 - 01/2015
3	Ureteral Obstruction 07/2022 - 12/2020
3	Cicatrix (Scar) 07/2022 - 12/2018
3	Osteoporosis 03/2022 - 03/2013
3	COVID-19 10/2021 - 11/2020
3	Burns 01/2021 - 11/2018
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 05/2012
3	Weight Gain 01/2021 - 09/2020
3	Pain (Aches) 01/2021 - 05/2014
3	Nasopharyngeal Carcinoma 01/2021 - 01/2019
3	Insulin Resistance 01/2021 - 03/2019
3	Schizophrenia (Dementia Praecox) 12/2020 - 02/2016
3	Hypoxia (Hypoxemia) 01/2020 - 03/2015
3	Hypertension (High Blood Pressure) 09/2019 - 11/2017
3	Carcinoma (Carcinomatosis) 01/2018 - 08/2009

Drug/Important Bio-Agent (IBA)

44	Proteins (Proteins, Gene)FDA Link 07/2022 - 05/2006
29	Pharmaceutical PreparationsIBA 03/2022 - 10/2012
19	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2020 - 10/2012
12	Histones (Histone)IBA 01/2022 - 08/2010
12	ChromatinIBA 01/2022 - 09/2011
10	Lysine (L-Lysine)FDA Link 01/2022 - 08/2010
9	EnzymesIBA 10/2021 - 04/2018
9	Biomarkers (Surrogate Marker)IBA 01/2021 - 04/2014
9	Phosphotransferases (Kinase)IBA 01/2019 - 09/2008
9	Paclitaxel (Taxol)FDA LinkGeneric 11/2017 - 09/2013
8	MethyltransferasesIBA 01/2022 - 01/2011
8	Polychlorinated Biphenyls (PCBs)IBA 01/2021 - 01/2019
7	Polycomb Repressive Complex 2IBA 07/2022 - 01/2015
7	Transcription Factors (Transcription Factor)IBA 01/2022 - 05/2006
7	LigandsIBA 01/2022 - 08/2012
7	Biological ProductsIBA 01/2020 - 10/2012
7	Transient Receptor Potential ChannelsIBA 10/2017 - 10/2012
6	MicroRNAs (MicroRNA)IBA 02/2022 - 05/2014
6	snake venom protein C activatorIBA 01/2022 - 01/2021
6	CytokinesIBA 01/2021 - 01/2014
6	AnthracyclinesIBA 10/2018 - 10/2014
5	CateninsIBA 07/2022 - 05/2015
5	Arginine (L-Arginine)FDA Link 01/2021 - 01/2011
5	taxaneIBA 10/2018 - 10/2014
5	Tacrolimus (Prograf)FDA LinkGeneric 01/2018 - 01/2016
5	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 03/2015 - 10/2012
4	Proteolysis Targeting ChimeraIBA 07/2022 - 01/2021
4	Small Interfering RNA (siRNA)IBA 06/2022 - 01/2017
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 07/2015
4	RNA (Ribonucleic Acid)IBA 01/2022 - 08/2017
4	graphene oxideIBA 01/2021 - 01/2019
4	ElementsIBA 01/2021 - 07/2016
4	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2021 - 12/2011
4	ErbB Receptors (EGF Receptor)IBA 01/2021 - 01/2014
4	Histone MethyltransferasesIBA 11/2020 - 01/2014
4	Phosphatidylinositols (Phosphatidylinositol)IBA 07/2019 - 05/2014
3	Enhancer of Zeste Homolog 2 ProteinIBA 07/2022 - 01/2015
3	DioxinsIBA 12/2021 - 04/2019
3	UNC1999IBA 11/2021 - 01/2015
3	Antiviral Agents (Antivirals)IBA 10/2021 - 03/2004
3	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2021 - 01/2017
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021 - 04/2012
3	Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)IBA 01/2021 - 01/2020
3	MicellesIBA 12/2020 - 01/2014
3	Antipsychotic Agents (Antipsychotics)IBA 12/2020 - 11/2011
3	Glucose (Dextrose)FDA LinkGeneric 02/2020 - 04/2013
3	Messenger RNA (mRNA)IBA 01/2020 - 12/2015
3	Adenosine Triphosphate (ATP)IBA 11/2019 - 01/2015
3	Environmental Pollutants (Pollutants, Environmental)IBA 07/2019 - 01/2019
3	Metformin (Glucophage)FDA LinkGeneric 03/2019 - 01/2016
3	Sirolimus (Rapamycin)FDA Link 03/2019 - 01/2016
3	Insulin (Novolin)FDA Link 03/2019 - 03/2017
3	Cadherins (E-Cadherin)IBA 01/2019 - 10/2017
3	Protein Isoforms (Isoforms)IBA 08/2018 - 03/2014
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2016 - 09/2012
3	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2016 - 01/2014

Therapy/Procedure

45	Therapeutics 02/2022 - 04/2012
23	Drug Therapy (Chemotherapy) 02/2022 - 10/2012
5	Thyroidectomy 03/2022 - 01/2015
4	Neoadjuvant Therapy 10/2022 - 04/2016
4	Transplantation 01/2021 - 01/2016
3	Hematopoietic Stem Cell Transplantation 01/2021 - 01/2017